New EU Approvals
Executive Summary
Six new products, including Europe's first two CAR T-cell therapies, have been added to the Pink Sheet’s 2018 list of EU centralized approvals of new active substances. The list includes brand name, generic name, company, therapeutic category/indication, date of marketing authorization and product type (e.g., medicine, vaccine, biologic).